Showing 36,902 results

Filters
PrEP programmes & uptake

Most High-Risk Men Don’t Take PrEP to Prevent H.I.V.

Editor's pick
The New York Times
25 July 2019
Child developmental issues

Folic acid reduces risk of defects linked to dolutegravir

Editor's pick
Baylor College of Medicine
25 July 2019
Transgender people

New data on HIV incidence among trans women in San Francisco

Editor's pick
San Francisco AIDS Foundation
25 July 2019
Starting treatment

Africa: What are we to make of the ADVANCE trial results?

Editor's pick
Spotlight
25 July 2019
Reproductive health

After Echo: ‘Life for young women navigating puberty is gruesome’

Editor's pick
Bhekisisa
26 July 2019
Employment

How one nurse’s experience of stigma at work led to change for all healthcare workers living with HIV

Editor's pick
NAT
26 July 2019
Employment

Military Experts, Medical Associations and HIV Advocates Oppose Trump DOD’s Discharge Policy for HIV-Positive Airmen

Editor's pick
Lambda Legal
26 July 2019
Government, leadership & policy

Is the HIV/AIDS response in jeopardy in Mexico?

Editor's pick
The Lancet HIV
26 July 2019
Changing treatment

Biktarvy Suppresses HIV Well in Women and Those With Drug Resistance

Editor's pick
POZ
29 July 2019
Undetectable viral load & treatment as prevention

What a U=U Leader Thinks About the CDC’s Updated Data on HIV Risk

Editor's pick
POZ
29 July 2019
PrEP science

#IAS2019: PrEP implants could revolutionise HIV prevention

Editor's pick
Health-e
29 July 2019
Activism & civil society

Women activists say the TAC’s time is up

Editor's pick
Health-e
29 July 2019
Treatment for women

What’s in a pill? Promise, uncertainty, rands, lives & loves … but rights? What the next big thing in HIV treatment for SA shows us

Editor's pick
Bhekisisa
29 July 2019
Conference announcements & declarations

IAS 2019: A week in review

Editor's pick
International AIDS Society
29 July 2019
People with limited treatment options

EMA panel recommends ibalizumab for multidrug-resistant HIV-1

Editor's pick
Medscape (requires free registration)
30 July 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits regulatory application to EMA for the first monthly, injectable treatment for HIV

Editor's pick
ViiV press release
30 July 2019
HIV & criminal law

Getting to zero? HIV criminalization and treatment adherence surveillance

Editor's pick
CATIE Blog
30 July 2019
Access to healthcare

Five years on, 3.9 million people in the developing world have access to HIV treatment dolutegravir, thanks to access-oriented voluntary licensing agreements

Editor's pick
Medicines Patent Pool
30 July 2019
Retention & linkage to care

Having Fallen Out of Care, Most Gay and Bisexual Men With Detectable HIV Viral Loads Were Successfully Reconnected, Study Finds

Editor's pick
TheBodyPro
1 August 2019
Cancer

HIV infection worsens cancer outcomes among elderly

Editor's pick
Healio
2 August 2019
People with limited treatment options

Clinical and Economic Effects of Ibalizumab for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
2 August 2019
The search for a cure

The State of Cure Research for HIV and Hepatitis B: Similarities and Differences

Editor's pick
TheBodyPro
2 August 2019
Changing treatment

High efficacy from switching to bictegravir/F/TAF in virally suppressed participants – including analyses by baseline drug resistance

Editor's pick
i-Base
2 August 2019
Conference announcements & declarations

Reflections from IAS 2019: Policies to End the HIV/AIDS Epidemic

Editor's pick
Friends of the Global Fight
2 August 2019